About this trial
This study aims to evaluate the possible efficacy of l-carnitine in critically ill hepatic patients admitted to intensive care unit.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age more than 18 years old
Acute-on-chronic liver failure (ACLF)
Hepatic encephalopathy
spontaneous bacterial peritonitis (SBP)
Disqualifiers
Age of less than 18 years old
Pregnancy or Lactation
patients have seizure
patient on warfarin
Trial design
Parallel
Treatments tested in this trial
L Carnitine
DrugL-Carnitine, a natural substance present in the body, is essential for energy metabolism in mammals. l-carnitine presents as a drug.
Standard medical treatment
DrugStandard medical treatment for hepatic patient admitted to icu
Treatment groups
Trial outcomes
Primary outcomes
laboratory value: serum creatinine(SCr)
laboratory value: international normalized ratio
laboratory value: Blood urea nitrogen(BUN)
laboratory value: Albumin
Other outcomes
• hospitalization stay in ICU
Sponsors and contacts
Click on the lead sponsor to view all of their trials.